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Changing Trends in the Landscape of Patients
Hospitalized With Acute Myocardial Infarction
(2001 to 2011) (from the Worcester Heart Attack Study)
Regino Mercado-Lubo, MD, MSCI, Jorge Yarzebski, MD, MPH, Darleen Lessard, MS,
Joel Gore, MD, and Robert J. Goldberg, PhD*
During the past several decades, new diagnostic tools, interventional approaches, and pop-
ulation-wide changes in the major coronary risk factors have taken place. However, few
studies have examined relatively recent trends in the demographic characteristics, clinical
profile, and the short-term outcomes of patients hospitalized for acute myocardial infarc-
tion (AMI) from the more generalizable perspective of a population-based investigation.
We examined decade long trends (2001 to 2011) in patient’s demographic and clinical
characteristics, treatment practices, and hospital outcomes among residents of theWorces-
ter metropolitan area hospitalized with an initial AMI (n = 3,730) at all 11 greater Worces-
ter medical centers during 2001, 2003, 2005, 2007, 2009, and 2011. The average age of the
study population was 68.5 years and 56.9% were men. Patients hospitalized with a first
AMI during the most recent study years were significantly younger (mean age = 69.9 years
in 2001/2003; 65.2 years in 2009/2011), had lower serum troponin levels, and experienced a
shorter hospital stay compared with patients hospitalized during the earliest study years.
Hospitalized patients were more likely to received evidence-based medical management
practices over the decade long period under study. Multivariable-adjusted regression mod-
els showed a considerable decline over time in the hospital death rate and a significant
reduction in the proportion of patients who developed atrial fibrillation, heart failure, and
ventricular fibrillation during their acute hospitalization. These results highlight the
changing nature of patients hospitalized with an incident AMI, and reinforce the need
for surveillance of AMI at the community level. © 2019 The Author(s). Published by
Elsevier Inc. This is an open access article under the CC BY-NC-ND license. (http://
creativecommons.org/licenses/by-nc-nd/4.0/) (Am J Cardiol 2020;125:673−677)
Despite significant advances in patient management and
population-wide lifestyle changes in several predisposing
factors, acute myocardial infarction (AMI) continues to be
a major cause of morbidity and mortality in the United
States.1,2 A limited number of community-based studies
have described changes over time in the clinical epidemiol-
ogy and outcomes of patients hospitalized with AMI in the
United States.3 These studies include the Worcester Heart
Attack Study, the Minnesota Heart Survey, and Rochester
Epidemiology Project.4−12 However, few relatively recent
data exist describing the potentially changing landscape of
AMI at the community level. The primary objective of this
population-based study was to describe decade long trends
in the demographic and clinical characteristics, hospital
management practices, and in-hospital clinical outcomes
among residents of central Massachusetts hospitalized with
a first AMI at all 11 metropolitan Worcester medical centers
on a biennial basis between 2001 and 2011.
Methods
Details of the Worcester Heart Attack Study have been
previously described.4−7 In brief, residents of the Worcester
metropolitan area hospitalized with a possible AMI at all 11
greater Worcester (MA) medical centers during 2001, 2003,
2005, 2007, 2009, and 2011 comprised the study popula-
tion. The medical records of residents of these patients
were individually reviewed and validated according to pre-
established criteria.5−8 Information was collected by trained
study staff about patient’s age, sex, co-morbidities, AMI
type (ST-segment elevation vs non-ST-segment elevation),
and occurrence of clinically significant hospital complica-
tions. Information was collected about the prescribing of
different cardiac medications during the patient’s acute hos-
pitalization and about the receipt of coronary diagnostic and
interventional procedures. Patients with a history of AMI
were excluded from the present study to provide insights
into the descriptive epidemiology of AMI among patients
with a first AMI.
To facilitate the interpretation of trends in the epidemiol-
ogy of AMI, the 6 one-year study years were aggregated
into 3 two-year periods, namely 2001 and 2003, 2005 and
2007, and 2009 and 2011. Differences in the distribution of
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demographic factors, medical history, physiologic findings,
clinical characteristics, and treatment practices were exam-
ined with the use of chi-square tests for trends and analysis
of variance for discrete and continuous variables, respec-
tively. To assess changes over time in the occurrence of
important clinical complications and in-hospital case-fatal-
ity rates, while controlling for potentially confounding fac-
tors of prognostic importance, several logistic multivariable
adjusted regression analyses were performed.
Results
This report is based on the 3,730 residents of the
Worcester metropolitan area who satisfied the diagnostic
criteria for an initial AMI. The mean age of study patients
was 68.5 years, 43.1% were women, and 89.9% were white.
Patients hospitalized with a first AMI during the most
recent study years were significantly younger compared
with patients who had been hospitalized in the earliest study
years (Table 1). There were a greater proportion of individ-
uals with previously diagnosed anemia, chronic kidney
disease, hyperlipidemia, hypertension, and peripheral vas-
cular disease during the most recent study years. A modest
decrease in mean systolic blood pressure and estimated glo-
merular filtration rate values was observed over time. There
was a decline in the mean serum troponin levels at the time
of hospital admission as well as in the average length of
hospital stay during the years under study (Table 1).
The in-hospital use of aspirin and lipid lowering agents
increased markedly during the years under study (Figure 1).
A statistically significant, but inconsistent increase in the
use of b-blockers was observed whereas there was a marked
decrease in the use of calcium channel blockers, diuretics,
and thrombolytic therapy (Figure 1). The proportion of
patients who underwent diagnostic cardiac catheterization
and a percutaneous coronary intervention (PCI) increased
markedly between 2001 and 2011. In 2009/2011, the per-
centage of hospitalized patients that received diagnostic
catheterization or a PCI was 72.0% and 54.7%, respectively
(Figure 2). The proportion of patients who underwent a sub-
sequent PCI following cardiac catheterization increased sig-
nificantly over time, whereas the proportion of patients who
underwent acute coronary artery bypass surgery declined.
In examining changes over time in the occurrence of
several major in-hospital complications and all-cause
in-hospital death rates, we observed a progressive decline
in the proportion of patients who developed ventricular
fibrillation, atrial fibrillation, and heart failure as well as a
marked decrease in hospital death rates (Table 2). Multivar-
iable adjusted regression analyses were performed to more
systematically examine trends in hospital death rates and in
major clinical complications (Table 3). Results of the unad-
justed analysis (model 1) showed significant declines over
time in the odds of dying in the hospital while declines in
the odds of developing atrial fibrillation, heart failure, and
ventricular fibrillation were noted. These results essentially
Table 1
Characteristics of patients Hospitalized with an initial acute myocardial iInfarction according to time period of hospitalization
Variable 2001/2003 (n = 1,547) 2005/2007 (n = 1,170) 2009/2011 (n = 1,013) p Value
Age (mean, years) 69.9 69.3 65.2
Age (years)
<55 17.8 % 19.1% 22.0%
55-64 17.5% 16.8% 21.5%
65-74 20.9% 17.9% 19.9%
75-84 27.2% 27.1% 18.3%
≥85 16.7% 19.1% 18.3% <0.001
Men 56.9% 54.9% 59.1% 0.09
White 87.9% 90.6% 91.9% <0.001
Length of stay (mean, days) 5.9% 5.7% 4.6% <0.001
Medical history
Angina 16.7% 8.9% 4.1% <0.001
Anemia 4.5% 11.8% 10.0% <0.001
CKD 11.8% 17.5% 18.0% <0.001
COPD 15.0% 16.5% 12.2% <0.005
Diabetes 28.0% 28.8% 31.7% 0.33
Heart failure 15.0% 16.5% 12.2% <0.005
Hyperlipidemia 44.2% 55.6% 65.6% <0.001
Hypertension 65.0% 70.6% 69.6% <.01
PVD 11.6% 16.3% 16.3% < 0.001
Stroke 9.3% 9.2% 7.5% 0.42
Systolic BP (mean, mm Hg) 143 142 140 0.08
Diastolic BP (mean, mm Hg) 79 78 79 0.08
eGFR (ml/min/1.73 m2) 60 62 54 <0.001
Serum Glucose (mean, mg/dl) 169 163 167 0.20
ST-segment elevation 39% 35% 35% 0.08
Troponin I (mean, ng/ml) 34 12 9 <0.001
CKD = Chronic kidney disease; COPD = chronic obstructive pulmonary disease; PVD = peripheral vascular disease; BP = blood pressure; eGFR = esti-
mated glomerular filtration rate.

































Figure 2. Changing trends in hospital coronary diagnostic and revascularization procedures. CABG = coronary artery bypass grafting; PCI = percutaneous
coronary intervention.
Table 2
Frequency of clinical outcomes according to time period of hospitalization
Complications 2001/2003 (n = 1,547) 2005/2007 (n = 1,170) 2009/2011 (n = 1,013) p Value
Atrial fibrillation 21.7% 21.5% 15.1% <0.005
Cardiogenic shock 4.9% 6.1% 4.6% 0.87
Death 9.6% 9.8% 6.5% <0.005
Heart failure 34.4% 33.9% 28.2% <0.05
Stroke 1.7% 0.6% 1.8% 0.88
Ventricular fibrillation 4.8% 3.8% 2.6% <0.05
Table 3
Multivariable-adjusted risk of in-hospital outcomes
Model 1 OR (95% CI) Model 2 OR (95% CI) Model 3 OR (95% CI)
Outcomes 2001/2003* 2005/2007 2009/2011 2005/2007 2009/2011 2005/2007 2009/2011
Atrial fibrillation 1 0.99 (0.82, 1.19) 0.65 (0.52, 0.80) 0.98 (0.799, 1.19) 0.71 (0.56, 0.89) 1.07 (0.87, 1.32) 0.81 (0.64, 1.03)
Cardiogenic shock 1 1.27 (0.91, 1.77) 0.95 (0.65, 1.38) 1.27 (0.90, 1.79) 0.97 (0.66, 1.43) 1.51 (1.06, 2.15) 1.25 (0.83, 1.87)
Death 1 1.03 (0.80, 1.33) 0.66 (0.49, 0.89) 1.02 (0.77, 1.34) 0.76 (0.55, 1.05) 1.02 (0.78, 1.34) 0.76 (0.55, 1.05)
Heart failure 1 0.98 (0.84, 1.15) 0.75 (0.63, 0.89) 0.91 (0.76, 1.09) 0.81 (0.66, 0.98) 1.02 (0.84, 1.23) 0.95 (0.77, 1.17)
Stroke 1 0.35 (0.15, 0.81) 1.05 (0.57, 1.93) 0.37 (0.16, 0.88) 1.39 (0.73, 2.66) 0.37 (0.16, 0.88) 1.39 (0.73, 2.66)
Ventricular fibrillation 1 0.80 (0.54, 1.16) 0.52 (0.33, 0.82) 0.82 (0.56, 1.21) 0.52 (0.33, 0.83) 0.88 (0.60, 1.30) 0.60 (0.38, 0.97)
Model 1: Unadjusted; Model 2: Adjusted for age, gender, race and medical history of: anemia, COPD, heart failure, hyperlipidemia, hypertension, PVD;
Model 3: Adjusted for characteristics in Model 2 plus type of AMI and hospital length of stay. COPD = chronic obstructive pulmonary disease; PVD = periph-
eral artery disease.
* Referent period.
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remained after adjusting for a variety of patient associated
demographic and clinical characteristics and duration of the
acute hospitalization (regression models 2 and 3) (Table 3).
Discussion
Our results highlight the changing landscape of patients
hospitalized with AMI at all medical centers in central Mas-
sachusetts. We found significant changes in the demographic
characteristics, clinical profile, and hospital management of
patients with a first AMI. Moreover, encouraging declines in
the proportion of patients who died or experienced major
clinical complications during their acute hospitalization were
observed.
Greater Worcester residents hospitalized with a first
AMI during the most recent study years were significantly
younger and more likely to be men. This shift to a younger
age at diagnosis is in contrast with those observed in the
Cardiovascular Research Network13 and the Rochester
Epidemiology project.14 Although the reasons underlying
differences in the findings between the present study and
other population-based studies are unknown, we believe
they could be due, in part, to the introduction of novel bio-
markers and the use of more sensitive diagnostic tests over
time as well as to differences in the sociodemographic and
clinical characteristics of the respective study populations.
If real, however, these changes could be the result of a
worsening coronary risk factor profile in residents of the
Worcester metropolitan area, creating a younger vulnerable
population at risk for acute coronary disease.
We observed marked changes over time in the occur-
rence of clinically important chronic diseases in our patient
population. This shift in patient profile toward the admis-
sion of predominantly younger patients with a greater prev-
alence of co-morbidities could be secondary to changes
in clinical guidelines for the identification of patients with
various chronic conditions that took place during the years
under study.15,16 We observed a steady decline in the aver-
age length of hospital stay for residents of the Worcester
metropolitan area hospitalized with a first AMI, likely due
to improved treatment strategies and cost considerations.
Patients with an incident AMI were more likely to have
developed a non-ST-segment elevation myocardial infarc-
tion during the years under study, results consistent with
trends observed in the Rochester epidemiology project dur-
ing a relatively similar period.11 Our data also showed that
serum troponin levels decreased considerably. Although
this could be an artifact created by the introduction of high-
sensitivity troponin assays and new test guidelines, the
lower serum troponin levels observed over time, and the
increasing proportion of smaller infarcts as reflected by
patient’s serial electrocardiogram findings, may be sugges-
tive of a progressive decline in the severity of patients hos-
pitalized with a first AMI during the period under study.
A number of community-based studies, including previ-
ous reports from the Worcester Heart Attack Study,4,10,13,17
as well as large coronary disease registries,18 have shown
evidence of a progressive increase in the prescribing
of effective cardiac therapies in patients hospitalized
with AMI during the past 2 decades. Moreover, a gradual
reduction in the utilization of cardiac medications with
questionable therapeutic value or a narrow therapeutic/toxic
ratio was observed. Increases in the proportion of patients
that underwent nonsurgical revascularization and diagnostic
procedures were noted, consistent with evidence-based
guidelines for the hospital management of patients with
AMI. As new treatment recommendations and approaches
evolve, it remains of importance to monitor trends in the
management of these patients and factors associated with
different treatment approaches and patient’s in-hospital and
long-term outcomes.
A marked change over time in the occurrence of clini-
cally important AMI-related complications was observed in
our patient population. We found a significant reduction in
the proportion of patients who developed atrial fibrillation,
heart failure, and ventricular fibrillation. These meaningful
changes are consistent with other findings.19−21 We docu-
mented a significant increase in patient’s in-hospital sur-
vival, a finding consistent with previous reports from this
study during earlier periods.4,17 These findings are consis-
tent with those derived from population-based studies
in Northern California and Minneapolis/St Paul, Minne-
sota10,13 and studies in Canada, Europe, and Australia.22,23
The strengths of our investigation include a large com-
munity-based population of patients hospitalized with
confirmed initial AMI at all central Massachusetts medical
centers. Our study cohorts were, however, comprised
largely of Caucasians and may lack generalizability to other
race/ethnic groups. The influence of possible changes
over time in the magnitude of out-of-hospital deaths due to
cardiac disease or changes in the occurrence of silent unrec-
ognized AMIs on the characteristics and outcomes of
patients hospitalized with AMI remains unknown.
In conclusion, the results of this study highlight the
changing demographic and clinical nature of patients hospi-
talized with AMI and the importance of surveillance at the
community level.
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